92 related articles for article (PubMed ID: 33428592)
1. Identification and validation of regulatory T cell-associated gene signatures to predict colon adenocarcinoma prognosis.
Zhao X; Li X; Miao Z
Int Immunopharmacol; 2024 May; 132():112034. PubMed ID: 38588631
[TBL] [Abstract][Full Text] [Related]
2. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3.
Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J
Technol Cancer Res Treat; 2023; 22():15330338231195494. PubMed ID: 37650153
[No Abstract] [Full Text] [Related]
3. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract][Full Text] [Related]
4. PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma.
Liu Y; Wang Y; Feng H; Ma L; Liu Y
Front Endocrinol (Lausanne); 2024; 15():1344058. PubMed ID: 38501104
[TBL] [Abstract][Full Text] [Related]
5. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.
Cui Y; Lv P; Zhang C
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929
[TBL] [Abstract][Full Text] [Related]
6. IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma.
Shao YJ; Ni JJ; Wei SY; Weng XP; Shen MD; Jia YX; Meng LN
Medicine (Baltimore); 2020 Sep; 99(37):e22170. PubMed ID: 32925784
[TBL] [Abstract][Full Text] [Related]
7. Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing.
Jia M; Liang J; Li Z; Qin Y; Li Q; Wang J; Lu X
Front Immunol; 2023; 14():1187160. PubMed ID: 37854594
[TBL] [Abstract][Full Text] [Related]
8. Integrative deep learning analysis improves colon adenocarcinoma patient stratification at risk for mortality.
Zhou J; Foroughi Pour A; Deirawan H; Daaboul F; Aung TN; Beydoun R; Ahmed FS; Chuang JH
EBioMedicine; 2023 Aug; 94():104726. PubMed ID: 37499603
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary dynamics of neoantigens in growing tumors.
Lakatos E; Williams MJ; Schenck RO; Cross WCH; Househam J; Zapata L; Werner B; Gatenbee C; Robertson-Tessi M; Barnes CP; Anderson ARA; Sottoriva A; Graham TA
Nat Genet; 2020 Oct; 52(10):1057-1066. PubMed ID: 32929288
[TBL] [Abstract][Full Text] [Related]
10. Mutational signatures in colon cancer.
Pandey P; Yang Z; Shibata D; Marjoram P; Siegmund KD
BMC Res Notes; 2019 Dec; 12(1):788. PubMed ID: 31796096
[TBL] [Abstract][Full Text] [Related]
11. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer.
Yu Y; Zhang J; Ni L; Zhu Y; Yu H; Teng Y; Lin L; Xue Z; Xue X; Shen X; Song H; Su X; Sun W; Cai Z
Hum Vaccin Immunother; 2022 Dec; 18(1):1-11. PubMed ID: 33689574
[TBL] [Abstract][Full Text] [Related]
12.
Zheng S; Liu D; Wang F; Jin Y; Zhao S; Sun S; Wang S
Front Genet; 2022; 13():906326. PubMed ID: 35783291
[No Abstract] [Full Text] [Related]
13. Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors.
Wang D; Chen X; Du Y; Li X; Ying L; Lu Y; Shen B; Gao X; Yi X; Xia X; Sui X; Shu Y
Front Immunol; 2022; 13():799988. PubMed ID: 35281032
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate genes encoding tumor-specific neoantigens in early- and late-stage colon adenocarcinoma.
Wang C; Xue W; Zhang H; Fu Y
Aging (Albany NY); 2021 Jan; 13(3):4024-4044. PubMed ID: 33428592
[TBL] [Abstract][Full Text] [Related]
15. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
16. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
18. Screening key long non-coding RNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Liu JX; Li W; Li JT; Liu F; Zhou L
Epigenomics; 2018 Sep; 10(9):1215-1228. PubMed ID: 30182733
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
